Esperance BectonAssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail202-747-3230 Professional Biography Esperance Becton is an associate in the Corporate Practice Group in the firm’s Washington, D.C. office and a member of the Healthcare Industry team. More Legal and Business Bylines From Esperance Becton Over 940,000 Medicare Beneficiaries Impacted by Data Breach - (Posted On Wednesday, October 23, 2024) Navigating the Complex Landscape of AI Governance: Principles and Frameworks for Responsible Innovation - (Posted On Wednesday, September 04, 2024) Key Elements of an AI Governance Program in Healthcare - (Posted On Thursday, August 29, 2024) The PACE Solution to Increasing Demands for Long-Term Services and Supports in the U.S. - (Posted On Thursday, November 02, 2023) Telehealth in a Post-PHE World - (Posted On Friday, March 03, 2023) Current Legal Analysis FINRA Facts and Trends: November 2024 by: Joshua Klein , Russell W. Gallaro Dividing Cryptocurrency in a New Jersey Divorce: What You Need to Know by: Louis M. Ragone New Pay Transparency Law to Go into Effect Beginning June 1, 2025 by: Ari G. Burd , Jeri L. Abrams BREAKING: Massachusetts Passes Clean Energy Bill Streamlining Permitting Process for Battery Energy Storage Systems by: Andrew O. Kaplan , Daniel J. Bailey Should Law Schools Teach The California Constitution? by: Keith Paul Bishop Website Use of Third-Party Tracking Software Not Prohibited Under Massachusetts Wiretap Act by: Hunton Andrews Kurth’s Privacy and Cybersecurity Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 21 2024 Third-Party Litigation Funding through a Transatlantic Lens Nov 21 2024 CC&Rs and Easements for Mixed-Use Projects: Best Practices for Developers Nov 21 2024 AI Patent Eligibility: Processing the USPTO's New Guidance Nov 21 2024 Update of 2024 California Employment Law Cases Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Dec 4 2024 TSCA 30/30 - December 4, 2024 Print
